IMR Press / FBL / Volume 21 / Issue 4 / DOI: 10.2741/4423

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Pathophysiology of neutrophil-mediated extracellular redox reactions

Show Less
1 Anti Doping Lab Qatar, Toxicology and Multipurpose Department, Doha, Qatar
2 Laboratory for Oxidative Stress, Rudjer Boskovic Institute, HR-10002 Zagreb, Croatia
3 Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria
Front. Biosci. (Landmark Ed) 2016, 21(4), 839–855; https://doi.org/10.2741/4423
Published: 1 January 2016
Abstract

Neutrophil granulocyte leukocytes (neutrophils) play fundamental role in the innate immune response. In the presence of adequate stimuli, neutrophils release excessive amount of reactive oxygen species (ROS) that may induce cell and tissue injury. Oxidative burst of neutrophils acts as a double-edged sword. It may contribute to the pathology of atherosclerosis and brain injury but is also necessary in resolving infections. Moreover, neutrophil-derived ROS may also have both a tumor promoting and tumor suppressing role. ROS have a specific activities and diffusion distance, which is related to their short lifetime. Therefore, the manner in which ROS will act depends on the cells targeted and the intra- and extracellular levels of individual ROS, which can further cause production of reactive aldehydes like 4-hydroxynonenal (HNE) that act as a second messengers of ROS. In this review we discuss the influence of neutrophil mediated extracellular redox reactions in ischemia reperfusion injury, transplant rejection and chronic diseases (atherosclerosis, inflammatory bowel diseases and cancer). At the end a brief overview of cellular mechanisms to maintain ROS homeostasis is given.

Keywords
Neutrophils
Oxidative Burst
Chronic Diseases
Ischemia Reperfusion
Transplantation Injury
Cancer
Review
Share
Back to top